Shares of Jump Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer presented a $58.9 million interior most investment led …
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.